Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Yung-Jue Bang

MD, PhD

🏢Seoul National University Hospital🌐South Korea

Professor, Department of Internal Medicine

105
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Yung-Jue Bang is a pioneering figure in gastric cancer research who led the landmark ToGA trial establishing trastuzumab as standard of care for HER2-positive gastric cancer. His contributions to molecular classification and targeted therapy development have fundamentally shaped treatment approaches. He continues to drive innovation in novel targets including Claudin 18.2 and FGFR2.

Share:

🧪Research Fields 研究领域

Gastric cancer
HER2-targeted therapy
Molecular oncology
Clinical trials
Precision gastric oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Yung-Jue Bang 的研究动态

Follow Yung-Jue Bang's research updates

留下邮箱,当我们发布与 Yung-Jue Bang(Seoul National University Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment